Auditor Michael Gillespie & Associates agrees with Item 4.02 disclosures
Michael Gillespie & Associates, PLLC has confirmed agreement with Goldenwell Biotech's statements regarding auditor changes filed on May 26, 2026. This auditor acknowledgment letter is a standard regulatory requirement when companies change accounting firms.
View filing at SEC.gov →